GSK announced it has formed a new collaboration with the São Paulo Research Foundation (FAPESP) to create a new Centre of Excellence for Sustainable Chemistry in Brazil. The agreement was reached after a meeting between Rogerio Ribeiro, senior vice president, Emerging Markets & Asia Pacific, GSK; Geraldo Alckmin, governor of São Paulo State; and Celso Lafer, president of FAFESP.“GSK has a vibrant and growing business in Brazil and, as part of our continued investment in science in Brazil, we are delighted to announce our support for the new sustainable chemistry center. This will be an important enabler towards our goal of reducing the environmental impact of both the discovery and subsequent manufacturing of drugs to help us meet our target of being carbon neutral by 2050,” said Ribeiro.
The Centre of Excellence will be located in the state of São Paulo and will focus on sustainable chemistries most relevant to the discovery and development of medicines. GSK has agreed in principle to co-fund the center with FAPESP, investing approximately £400,000 per year during a ten-year collaboration which will be matched by FAPESP.
GSK is already supporting a Centre of Excellence for Sustainable Chemistry in the UK based at The University of Nottingham. Once the new center in São Paulo is established, it will form scientific links with GSK and The University of Nottingham to facilitate the sharing of knowledge and expertise between Brazilian and UK researchers.
“FAPESP has formed partnerships to create world class research centers, such as this new collaboration with GSK. By applying interdisciplinary approaches to complex scientific challenges through this collaboration with GSK, FAPESP contributes to a knowledge advance in sustainable chemistry and the development of applications in areas of common interest,” said Lafer.
Professor Chris Moody, the Sir Jesse Boot Professor at the University of Nottingham, said: “We are delighted to extend our collaboration with GSK into this new venture in Brazil. The Nottingham Centre of Excellence for Sustainable Chemistry that will be housed in a unique Carbon Neutral Building now being built on our Jubilee Campus, will be ideally placed to run a wide range of collaborative projects. We are looking forward to working with Brazilian colleagues.”
This latest announcement builds on GSK’s existing partnership with FAPESP to build a sustainable, long-term scientific research presence in Brazil. Through its “Trust in Science” program, GSK aims to support outstanding scientific groups in Latin America to validate and explore compelling ideas to treat priority diseases, including those that have a substantial impact on the health of Latin America.
Date: October 25, 2013
Source: GSK
Filed Under: Drug Discovery
